More recently, smac/diablo-derived peptides, have been shown to sensitise tumour cells to Apo2/TRAIL or anticancer drug-induced apoptosis in gliomas in vivo (Fulda et al, 2002). Here, TNFRSF10A is linked to neoplasm.